Effect of obesity on sexual functioning among gynecologic cancer patients receiving radiotherapy

Background: Both obesity and sexual dysfunction are common in gynecologic cancer patients. We aimed to examine the effect of obesity on sexual functioning in gynecologic cancer patients receiving radiotherapy and explore the difference by obesity measures. Methods: In this secondary analysis of a prospective observational study, obesity was measured by body mass index (BMI) and body fat percentage (BFP). BFP was estimated using the Clinica Universidad de Navarra-Body Adiposity Estimator. Sexual functioning and physical and emotional well-being were assessed pre-radiotherapy by Female Sexual Function Index and Functional Assessment of Cancer Therapy-General. Sexual functioning was reassessed at six months post-radiotherapy. We used generalized linear models to examine the effect of obesity on sexual functioning and mediation analysis to identify the indirect effect of obesity on sexual functioning through physical and emotional well-being. Results: The 54 eligible gynecologic cancer (24 cervical and 30 endometrial) patients were Black (48.1%), in a married/domestic partnership (51.9%), and had a history of prior treatment (59.3%). Patients without obesity reported slightly worse sexual functioning than those with obesity pre-radiotherapy (BMI-based obesity p = 0.012, BFP-based obesity p = 0.033), but regardless of obesity, patients showed extremely poor sexual functioning, which continued post-radiotherapy. After adjusting for cancer type and history of prior treatment, we found no association between obesity and sexual functioning pre-radiotherapy. However, BFP-based obesity had a negative effect on the changes in sexual functioning from pre- to post-radiotherapy (p = 0.013) while BMI-based obesity had no effect. The effect of obesity on sexual functioning was mediated by neither physical nor emotional well-being. Conclusions: Obesity, when measured by BFP, was associated with delayed recovery of sexual functioning in women with gynecologic cancer after radiotherapy. Further work with rigorous measurement of obesity could help provide definitive evidence of the association between obesity and sexual functioning in this population.

Sexual function; Obesity; Body mass index; Body fat percentage; Gynecologic cancer; Radiotherapy

[1] Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2024; 74: 229–263.

[2] Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA: A Cancer Journal for Clinicians. 2021; 71: 7–33.

[3] Felix AS, Sherman ME. Implications of the obesity epidemic for endometrial cancer risk, mortality, and survivorship. Gynecologic Oncology. 2021; 160: 643–645.

[4] Fielder R. Sexual functinoing. In Gellman MD, Turner JR (eds.) Encyclopedia of behavioral medicine (pp. 1774–1777). 1st den. Springer: New York, NY. 2013.

[5] Garcia RM, Hanlon A, Small W, Strauss JB, Lin L, Wells J, et al. The relationship between body mass index and sexual function in endometrial cancer. Oncology Nursing Forum. 2018; 45: 25–32.

[6] Qian M, Wang L, Xing J, Shan X, Wu J, Liu X. Prevalence of sexual dysfunction in women with cervical cancer: a systematic review and meta-analysis. Psychology, Health & Medicine. 2023; 28: 494–508.

[7] Esmat Hosseini S, Ilkhani M, Rohani C, Nikbakht Nasrabadi A, Ghanei Gheshlagh R, Moini A. Prevalence of sexual dysfunction in women with cancer: a systematic review and meta-analysis. International Journal of Reproductive BioMedicine. 2022; 20: 1–12.

[8] de Morais Siqueira T, Derchain S, Juliato CRT, Pinto e Silva MP, Machado HC, Brito LGO. Vaginal stenosis in women with cervical or endometrial cancer after pelvic radiotherapy: a cross-sectional study of vaginal measurements, risk for sexual dysfunction and quality of life. International Urogynecology Journal. 2022; 33: 637–649.

[9] Matanes E, Linder R, Lauterbach R, Mick I, Matanis J, Abdah-Bortnyak R, et al. The impact of radiation therapy on vaginal biomechanical properties. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2021; 264: 36–40.

[10] Smith T, Kingsberg SA, Faubion S. Sexual dysfunction in female cancer survivors: addressing the problems and the remedies. Maturitas. 2022; 165: 52–57.

[11] Salari N, Hasheminezhad R, Sedighi T, Zarei H, Shohaimi S, Mohammadi M. The global prevalence of sexual dysfunction in obese and overweight women: a systematic review and meta-analysis. BMC Women’s Health. 2023; 23: 375.

[12] Vaidya R, Till C, Greenlee H, Hershman DL, Unger JM. Trends in obesity prevalence among patients enrolled in clinical trials for obesity-related cancers, 1986 to 2016. JAMA Network Open. 2022; 5: e2234445.

[13] Lee H, Reilly M, Bruner DW, Bai J, Hu YJ, Yeager KA. Obesity and patient-reported sexual health outcomes in gynecologic cancer survivors: a systematic review. Research in Nursing & Health. 2022; 45: 664–679.

[14] Stephenson J, Smith CM, Kearns B, Haywood A, Bissell P. The association between obesity and quality of life: a retrospective analysis of a large-scale population-based cohort study. BMC Public Health. 2021; 21: 1990.

[15] Lee KC, Chung KC, Chen HH, Cheng KC, Wu KL, Song LC. The impact of obesity on postoperative outcomes in colorectal cancer patients: a retrospective database study. Supportive Care in Cancer. 2022; 30: 2151–2161.

[16] Palanivel JA, Millington GWM. Obesity-induced immunological effects on the skin. Skin Health and Disease. 2023; 3: e160.

[17] Delishaj D, Barcellini A, D’Amico R, Ursino S, Pasqualetti F, Fumagalli IC, et al. Vaginal toxicity after high-dose-rate endovaginal brachytherapy: 20 years of results. Journal of Contemporary Brachytherapy. 2018; 10: 559–566.

[18] Avishai E, Yeghiazaryan K, Golubnitschaja O. Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine. The EPMA Journal. 2017; 8: 23–33.

[19] Banack HR, Wactawski-Wende J, Hovey KM, Stokes A. Is BMI a valid measure of obesity in postmenopausal women? Menopause. 2018; 25: 307–313.

[20] Tsementzi D, Pena-Gonzalez A, Bai J, Hu YJ, Patel P, Shelton J, et al. Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women. Cancer Medicine. 2020; 9: 3714–3724.

[21] Gómez-Ambrosi J, Silva C, Catalán V, Rodríguez A, Galofré JC, Escalada J, et al. Clinical usefulness of a new equation for estimating body fat. Diabetes Care. 2012; 35: 383–388.

[22] Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. The American Journal of Clinical Nutrition. 2000; 72: 694–701.

[23] Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. Journal of Sexual Medicine. 2000; 26: 191–208.

[24] Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. Journal of Sex & Marital Therapy. 2005; 31: 1–20.

[25] Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. Journal of Clinical Oncology. 1993; 11: 570–579.

[26] Boehmer U, Timm A, Ozonoff A, Potter J. Applying the female sexual functioning index to sexual minority women. Journal of Women’s Health. 2012; 21: 401–409.

[27] Hayes AF. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. In Little TD (ed.) Methodology in the social sciences series (pp. 75–216). 3rd edn. The Guilford Press: New York, NY. 2018.

[28] Lindsey JK, Jones B. Choosing among generalized linear models applied to medical data. Statistics in Medicine. 1998; 17: 59–68.

[29] Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods. 2007; 39: 175–191.

[30] Kumar RV, Bhasker S. Obesity in patients with carcinoma cervix increases the risk of adverse events. Reports of Practical Oncology & Radiotherapy. 2020; 25: 212–216.

[31] Corbeau A, Heemsbergen WD, Kuipers SC, Godart J, Creutzberg CL, Nout RA, et al. Predictive factors for toxicity after primary chemoradiation for locally advanced cervical cancer: a systematic review. International Journal of Radiation Oncology Biology Physics. 2024; 119: 127–142.

[32] Pearman T, Yanez B, Peipert J, Wortman K, Beaumont J, Cella D. Ambulatory cancer and US general population reference values and cutoff scores for the functional assessment of cancer therapy. Cancer. 2014; 120: 2902–2909.

[33] Austria MD, Lynch K, Le T, Walters CB, Atkinson TM, Vickers AJ, et al. Sexual and gender minority persons’ perception of the female sexual function index. Journal of Sexual Medicine. 2021; 18: 2020–2027.

[34] Jennings KJ, de Lecea L. Neural and hormonal control of sexual behavior. Endocrinology. 2020; 161: bqaa150.